Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
5.20
-0.21 (-3.88%)
May 9, 2025, 11:29 AM - Market open
Vir Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 20.86 | 74.21 | 86.18 | 1,616 | 1,095 | 76.37 | Upgrade
|
| Revenue Growth (YoY) | -73.79% | -13.89% | -94.67% | 47.50% | 1334.39% | 843.86% | Upgrade
|
| Cost of Revenue | 471.99 | 478.65 | 572.83 | 620.97 | 513.87 | 301.58 | Upgrade
|
| Gross Profit | -451.13 | -404.44 | -486.65 | 994.83 | 581.54 | -225.21 | Upgrade
|
| Selling, General & Admin | 106.65 | 119.03 | 174.44 | 161.76 | 160.79 | 70.94 | Upgrade
|
| Operating Expenses | 131.77 | 119.03 | 174.44 | 161.76 | 160.79 | 70.94 | Upgrade
|
| Operating Income | -582.9 | -523.47 | -661.09 | 833.07 | 420.75 | -296.15 | Upgrade
|
| Interest & Investment Income | 62.81 | 71.81 | 86.99 | 28.09 | 0.44 | 2.84 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.01 | -2.22 | -8.99 | 4.26 | -9.44 | -4.47 | Upgrade
|
| EBT Excluding Unusual Items | -522.09 | -453.88 | -583.09 | 865.42 | 411.75 | -297.78 | Upgrade
|
| Merger & Restructuring Charges | -35.03 | -35 | -13.56 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.77 | -5.53 | -21.89 | -111.14 | 138.05 | - | Upgrade
|
| Asset Writedown | -14.55 | -14.55 | -9.66 | - | - | -0.83 | Upgrade
|
| Other Unusual Items | -14.15 | -14.15 | - | - | - | - | Upgrade
|
| Pretax Income | -579.05 | -523.11 | -628.19 | 754.28 | 549.8 | -298.61 | Upgrade
|
| Income Tax Expense | -1.41 | -1.15 | -13.08 | 238.44 | 21.22 | 0.05 | Upgrade
|
| Earnings From Continuing Operations | -577.65 | -521.96 | -615.12 | 515.84 | 528.58 | -298.67 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.06 | - | - | - | Upgrade
|
| Net Income | -577.65 | -521.96 | -615.06 | 515.84 | 528.58 | -298.67 | Upgrade
|
| Net Income to Common | -577.65 | -521.96 | -615.06 | 515.84 | 528.58 | -298.67 | Upgrade
|
| Net Income Growth | - | - | - | -2.41% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 137 | 136 | 134 | 133 | 130 | 119 | Upgrade
|
| Shares Outstanding (Diluted) | 137 | 136 | 134 | 135 | 133 | 119 | Upgrade
|
| Shares Change (YoY) | 1.66% | 1.58% | -0.50% | 1.03% | 11.98% | 292.62% | Upgrade
|
| EPS (Basic) | -4.22 | -3.83 | -4.59 | 3.89 | 4.07 | -2.51 | Upgrade
|
| EPS (Diluted) | -4.22 | -3.83 | -4.59 | 3.83 | 3.96 | -2.51 | Upgrade
|
| EPS Growth | - | - | - | -3.28% | - | - | Upgrade
|
| Free Cash Flow | - | -453.65 | -800.36 | 1,595 | -69.41 | -197.49 | Upgrade
|
| Free Cash Flow Per Share | - | -3.33 | -5.97 | 11.83 | -0.52 | -1.66 | Upgrade
|
| Gross Margin | - | - | - | 61.57% | 53.09% | -294.90% | Upgrade
|
| Operating Margin | -2794.20% | -705.44% | -767.10% | 51.56% | 38.41% | -387.79% | Upgrade
|
| Profit Margin | -2769.04% | -703.40% | -713.69% | 31.92% | 48.25% | -391.09% | Upgrade
|
| Free Cash Flow Margin | - | -611.35% | -928.71% | 98.73% | -6.34% | -258.60% | Upgrade
|
| EBITDA | -569.22 | -508.91 | -641.64 | 839.85 | 426.56 | -290.71 | Upgrade
|
| EBITDA Margin | - | - | - | 51.98% | 38.94% | - | Upgrade
|
| D&A For EBITDA | 13.68 | 14.56 | 19.45 | 6.78 | 5.81 | 5.44 | Upgrade
|
| EBIT | -582.9 | -523.47 | -661.09 | 833.07 | 420.75 | -296.15 | Upgrade
|
| EBIT Margin | - | - | - | 51.56% | 38.41% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 31.61% | 3.86% | - | Upgrade
|
| Revenue as Reported | 20.86 | 74.21 | 86.18 | 1,616 | 1,095 | 76.37 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.